News

Announcement – CSO Appointment

We are excited to announce that Minttu Kansikas has been appointed as Chief Scientific Officer to lead the research efforts and laboratory functions. Congratulations! Minttu is a co-inventor and one of the leading scientists behind

... read more

Welcome to our updated Website

Welcome! We have updated our website and hope you enjoy the new structure and features! This new section being one of them, and the twitter feed, being another. And there are many more to come!

... read more

LS CancerDiag joins InvestHorizon Accelerator

LS CancerDiag joins the InvestHorizon Accelerator, we are delighted to have been accepted to the programme! InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding. The selected deep tech companies

... read more

🩺Did you know that 40% of cancer cases are preventable?

📝@EU_Commission's #BeatingCancerPlan aims to protect people from avoidable cancers, improve access to screening & early diagnosis

👉https://ec.europa.eu/info/strategy/priorities-2019-2024/promoting-our-european-way-life/european-health-union/cancer-plan-europe_en #EUCancerPlan #MissionCancer

Congratulations to our Six Scandinavian start-ups ready for EIT Health Catapult Semifinals @eithealth @cardiolyse @lscancerdiag @KamuHealth @Finnadvance https://www.mynewsdesk.com/se/eit-health-scandinavia/pressreleases/six-scandinavian-start-ups-ready-for-eit-health-catapult-semifinals-3109203

We have been selected as a semifinalist in the @EITHealth Catapult competition. Discover more about innovative projects for the healthcare industry. Don't miss out on the semifinals event on 1-3 December 2021!
https://eithealth.eventscase.com/EN/catapult_semifinals2021 #MissionCancer #LynchSyndrome #DiagMMR

Happy Friday everyone! The team is going strong with @EITHealth and @EITHealthScand with participation in various of their programmes this month! #EITHealth #accelerator #MissionCancer #LynchSyndrome #CancerPrevention #DiagMMR https://www.linkedin.com/feed/update/urn:li:activity:6801540648349536256

Load More...